Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects

Dihydroartemisinin-piperaquine is an artemisinin-based combination treatment (ACT) recommended by the WHO for uncomplicated Plasmodium falciparum malaria, and it is being used increasingly for resistant vivax malaria where combination with primaquine is required for radical cure. The WHO recently re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Hanboonkunupakarn, Borimas, Ashley, Elizabeth A., Jittamala, Podjanee, Tarning, Joel, Pukrittayakamee, Sasithon, Hanpithakpong, Warunee, Chotsiri, Palang, Wattanakul, Thanaporn, Panapipat, Salwaluk, Lee, Sue J., Day, Nicholas P. J., White, Nicholas J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2014
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249579/
https://ncbi.nlm.nih.gov/pubmed/25267661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03704-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars